Hims & Hers Health Cash on Hand 2020-2024 | HIMS

Hims & Hers Health cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Hims & Hers Health cash on hand for the quarter ending September 30, 2024 was $0.254B, a 19.56% increase year-over-year.
  • Hims & Hers Health cash on hand for 2023 was $0.221B, a 23.02% increase from 2022.
  • Hims & Hers Health cash on hand for 2022 was $0.18B, a 27.36% decline from 2021.
  • Hims & Hers Health cash on hand for 2021 was $0.247B, a 146.76% increase from 2020.
Hims & Hers Health Annual Cash on Hand
(Millions of US $)
2023 $221
2022 $180
2021 $247
2020 $100
2019 $2
2018 $
Hims & Hers Health Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $254
2024-06-30 $227
2024-03-31 $204
2023-12-31 $221
2023-09-30 $212
2023-06-30 $193
2023-03-31 $184
2022-12-31 $180
2022-09-30 $198
2022-06-30 $195
2022-03-31 $203
2021-12-31 $247
2021-09-30 $252
2021-06-30 $317
2021-03-31 $323
2020-12-31 $100
2020-09-30 $1
2020-06-30 $1
2020-03-31 $1
2019-12-31
2019-09-30 $2
2019-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.141B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00